It is currently Sat Jan 21, 2017 2:50 am

News News of ThisIsMS

Site map of ThisIsMS » Forum : ThisIsMS

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.

DR15 allele

<shortened url>
I wonder how to test for the above genetic coding. I would guess I have this genetic code.
Read more : DR15 allele | Views : 1321 | Replies : 0 | Forum : General Discussion


I guess this is a vote of confidence for ATL1102 from Teva. The phase 2a trial is scheduled to report results around the middle of this year.

Antisense Therapeutics Ltd Licenses ATL1102 to Teva Pharmaceutical

February 20, 2008 - Antisense Therapeutics announced on February 11, 2008 that the Company had entered into an exclusive, world-wide license agreement with Teva to develop and commercialize ATL1102, a drug discovered by Isis Pharmaceuticals Inc. and licensed to ANP. ...
Read more : ATL1102 | Views : 1951 | Replies : 2 | Forum : Drug Pipeline

Another stem cell research article

Human Stem Cells Produce Healthy Neural Stem Cells In Rats 20 February 2008

Neural cells derived from human embryonic stem cells helped repair stroke-related damage in the brains of rats and led to improvements in their physical abilities after a stroke, in a new study by researchers at the Stanford University School of Medicine.

This study marks the first time researchers have used human embryonic stem cells to generate neural cells that grow well ...
Read more : Another stem cell research article | Views : 1908 | Replies : 1 | Forum : Stem Cells

FDA Proposed Off-Label Marketing Rule Changes

I wonder how/if this would impact MS off-label treatments. I would hope some of the chemotherapy drugs would receive more attention and traction as MS treatments.

FDA on Friday proposed new guidelines that would allow pharmaceutical and medical device companies to market their products for off-label uses, the New York Times reports (Harris, New York Times, 2/16). Currently, physicians can prescribe medications and medical devices for off-label uses, but companies cannot market their products for ...
Read more : FDA Proposed Off-Label Marketing Rule Changes | Views : 1337 | Replies : 0 | Forum : General Discussion


I know the are a few thoughts out there that strictly targeting T-cells is incomplete. I haven't kept up on the Rituxan trials but received an e-mail today from the Myelin Repair Foundation (that' probably not exactly right) and there seem to be some good results.....except for the death thing. So is it time to look forward to the Tovaxin/Rituxan cocktail? Thoughts on the Rituxan trial? Anyone?
Read more : Rituxan | Views : 2264 | Replies : 3 | Forum : Tcelna (Tovaxin)

3 years on ldn

This week marks three-years I have been taking LDN. I took 3mg for most of the time and within the last few months have upped it to 4.5mg. There was no real reason to go to 4.5, I just knew from reading that it was the 'optimal' dosage for females if you could manage it and when I had a few days off in a row I started at 4mg (only side effect was some ...
Read more : 3 years on ldn | Views : 5386 | Replies : 9 | Forum : Low Dose Naltrexone

Rebif & shortness of breath

Well, my longtime drug Copaxone stopped working for me last Spring, and I'm now taking Rebif. Trouble is, now I get short of breath very easily (even 1 flight of stairs.) I'm a very fit 41 year-old, I exercise regularly, and eat well. I've been to a pulmonary specialist and all tests came back normal.

Is there anyone out there who's had a similar experience with Rebif? I'm getting ready to ditch this one too, ...
Read more : Rebif & shortness of breath | Views : 1455 | Replies : 0 | Forum : General Discussion

Potential new drug target

Brain drug target discovery in Multiple Sclerosis 18 February 2008
US researchers have found two potential targets for treating multiple sclerosis after an extensive trawl through proteins in the brain.

Comparison of 2,538 proteins from MS patients with those from healthy brains showed damage in two proteins not before linked to the disease.

In mice blocking the effects of the proteins led to reversal of symptoms, the study in Nature reported.

There are about 85,000 ...
Read more : Potential new drug target | Views : 2597 | Replies : 3 | Forum : Drug Pipeline

My NAG report

Okay so I've been taking N-acetylglucosamine for a few months now ,and while you've read about my success from it, I have found that Glucosamine Chondroitin (Triple Stregth) is much more effective. I feel almost like a kid after taking that. I'm consuming more Triple Strength Chondroitin than I am the NAG, although I still take it.

I just wish all my functions would come back 100%.

Damage is damage and as the Stones say, ...
Read more : My NAG report | Views : 1972 | Replies : 3 | Forum : General Discussion

mitoxantrone v cyclophosphamide

Read more : mitoxantrone v cyclophosphamide | Views : 4021 | Replies : 0 | Forum : Novantrone


Login  •  Register


Total posts 235757 • Total topics 25503 • Total members 16786

Contact us | Terms of Service